Relation Between Cellular Senescence and Liver Diseases

doi:10.1016/S1001-9294(16)30036-0

Abstract

Cellular senescence refers to a process that cellular proliferation and differentiation modulated by the multiple stimulating factors gradually decline. Aging cells present the irreversible stop of proliferation and differentiation and change in secretory function because the cell cycle of aging cells is steadily blocked at some point. It has have been shown that cellular senescence plays an important role in the occurrence and development of liver diseases. In this paper, we review the advances in relations between cellular senescence and liver diseases.

Key words: cellular senescence, mechanism, liver diseases, liver fibrosis, liver cancer

Guo-wen Li, Xue-feng Yang*, Nian Fu, Yan Ou-yang, Kai Qing. Relation Between Cellular Senescence and Liver Diseases[J].Chinese Medical Sciences Journal, 2016, 31(2): 121-126.

References 60

1.	Baker DJ, Wshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays aging-associated disorders. Nature 2011; 479:232-6.
2.	Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192:547-56.
3.	Kuilman T, Michaloglou C, Mooi WJ, et al. The essence of senescence. Genes Dev 2010; 24:2463-79.
4.	Yan HL, Gong YZ. Research advances on the relationship between cell senescence and oxidative stress, p16, p53/p 21. Med Recapitulate 2011; 5:682-5.
5.	Liu K, Feng T, Liu J, et al. Silencing of the DEK gene induces apoptosis and senescence in CaSki cervical carcinoma cells via the up-regulation of NF- κ B p65. Biosci Rep 2012; 32:323-32.
6.	Dimozi A, Mavrogonatou E, Sklirou A, et al. Oxidative stress inhibits the proliferation, induces premature senescence and promotes a catabolic phenotype in human nucleus pulposus intervertebral disc cells. Eur Cell Mater 2015; 30:89-102; discussion 103.
7.	Zhang W, Hui R, Yang S. Telomeres, cardiovascular aging, and potential intervention for cellular senescence. Sci Chin Life Sci 2014; 57:858-62.
8.	Suram A, Herbig U. The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses. Aging Cell 2014; 13:780-6.
9.	Abdallah P, Luciano P, Runge KW, et al. A two-step model for senescence triggered by a single critically short telomere. Nat Cell Biol 2009; 11:988-93.
10	Maicher A, Kastner L, Dees M, et al. Deregulated telomere transcription causes replication-dependent telomere shortening and promotes cellular senescence. Nucleic Acids Res 2012; 40:6649-59.
11	Feng X, Wang L, Li Y. Change of telomere length in angiotensin II-induced human glomerular mesangial cell senescence and the protective role of losartan. Mol Med Rep 2011; 4:255-60.
12	Bu DX, Johansson ME, Ren J, et al. Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair. Arterioscler Thromb Vasc Biol 2010; 30:2604-10.
13	Shen XH, Xu SJ, Jin CY, et al. Interleukin-8 prevents oxidative stress-induced human endothelial cell senescence via telomerase activation. Int Immunopharmacol 2013; 16:261-7.
14	Wang XB, Zhu L, Huang J, et al. Resveratrol-induced augmentation of telomerase activity delays senescence of endothelial progenitor cells. Chin Med J (Engl) 2011; 124:4310-5.
15	Nakayama Y, Yamaguchi N. Role of cyclin B1 levels in DNA damage and DNA damage-induced senescence. Int Rev Mol Biol 2013; 305:303-37.
16	Korwek Z, Alster O. The role of the DNA damage response in apoptosis and cell senescence. Postepy Biochem 2014; 60:248-62.
17	Zhan H, Suzuki T, Aizawa K, et al. Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence. J Biol Chem 2010; 285:29662-70.
18	Lee SJ, Lee SH, Yoon MH, et al. A new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation. Neoplasia 2013; 15:727-37.
19	Dikovskaya D, Cole JJ, Mason SM, et al. Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest. Cell?Rep 2015; 12:1483-96.
20	Rossiello F, Herbig U, Longhese MP, et al. Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and aging. Curr Opin Genet Dev 2014; 26:89-95.
21	Zhang DY, Wang HJ, Tan YZ. Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway. PLoS One 2011; 6:e21397.
22	Bennecke M, Kriegl L, Bajbouj M, et al. lnk4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell 2010; 18:135-46.
23	Ninomiya Y, Cui X, Yasuda T, et al. Arsenite induces premature senescence via p53/p21 pathway as a result of DNA damage in human malignant glioblastoma cells. BMB Rep 2014; 47:575-80.
24	Ding Y, Chen J, Okon IS, et al. Absence of AMPKα2 accelerates cellular senescence via p16 induction in mouse embryonic fibroblasts. Int J Biochem Cell Biol 2016; 71:72-80.
25	Bai J, Chen J, Ma M, et al. Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16. DNA Cell Biol 2014; 33:337-44.
	26.Wang Y, Wong MM, Zhang X, et al. Ectopic AP4 expression induces cellular senescence via activation of p53 in long-term confluent retinal pigment epithelial cells. Exp Cell Res 2015; 339:135-46.
	27.Kim RH, Kang MK, Kim T, et al. Regulation of p53 during senescence in normal human keratinocytes. Aging Cell 2015; 14:838-46.
	28.Jing X, Xiong XD, Liu XG. The role of miRNAs in aging-related signaling pathways. CJBMB 2013; 29:412-8.
29	Fusco S, Maulucci G, Pani G. Sirt1: defeating senescence? Cell Cycle 2012; 11:4135-46.
30	Bou KT, Futoma KE, Jacobsen A, et al. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011; 10:29.
	31.Xu D, Takeshita F, Hino Y, et al. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 2011; 193:409-24.
32	Yang Q, Wang B, Zang W, et al. Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One 2013; 8:e70627.
33	Dibble CC, Cantley LC. Regulation of mTORC1 by PI3K signaling. Trends Cell Biol 2015; 25:545-55.
34	Miyazaki M, McCarthy JJ, Esser KA, et al. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes. FEBS J 2010; 277:2180-91.
35	Zhang D, Yan B, Yu S, et al. Coenzyme Q10 inhibits the aging of mesenchymal stem cells induced by D-galactose through Akt/mTOR signaling. Oxid Med Cell Longev 2015; 2015:867293.
	36.Supanji, Shimomachi M, Hasan MZ, et al. HtrA1 is induced by oxidative stress and enhances cell senescence through p38 MAPK pathway. Exp Eye Res 2013; 112: 79-92.
37	Wang Y, Liu L, Zhou D. Inhibition of p38 MAPK attenuates ionizing radiation-induced hematopoietic cell senescence and residual bone marrow injury. Radiat Res 2011; 176:743-52.
	38.Chien Y, Scuoppo C, Wang X, et al. Control of the senescence-associated secretory phenotype by NF- κ B promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25:2125-36.
39	Rovillain E, Mansﬁeld L, Caetano C, et al. Activation of nuclear factor- κ B signaling promotes cellular senescence. Oncogene 2011; 30:2356-66.
40	Biron-Shental T, Amiel A, Anchidin R. Telomere length and telomerase reverse transcriptase mRNA expression in patients with hepatitis C. Hepatogastroenterology 2013; 60:1713-6.
	41.Lim JS, Park SH, Jang KL. Hepatitis C virus core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation. Cancer Lett 2012; 321:154-61.
42	Tachtatzis PM, Marshall A, Aravinthan A. Chronic hepatitis B virus infection: the relation between hepatitis B antigen expression, telomere length, senescence, inflammation and fibrosis. PLoS One 2015; 10:e0127511.
43	Idrissi ME, Hachem H, Koering C, et al. HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype. J Viral Hepat 2016; 23:130-8.
	44.Park SH, Jung JK, Lim JS, et al. Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation. J Gen Virol 2011; 92:1309-17.
45	Kew MC. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol 2011; 26 Suppl 1:144-52.
	46.Wan J, Benkdane M, Alons E. M2 kupffer cells promote hepatocyte senescence: an IL-6-dependent protective mechanism against alcoholic liver disease. Am J Pathol 2014; 184:1763-72.
47	Aravinthan A, Scarpini C, Tachtatzis P, et al. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. J Hepatol 2013; 58:549-56.
	48.Aravinthan A, Pietrosi G, Hoare M, et al. Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease. PLoS One 2013; 8:e72904.
49	Elpek G. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update. World J Gastroenterol 2014; 20:7260-76.
	50.Asahina K. Hepatic stellate cell progenitor cells. J Gastroenterol Hepatol 2012; 27 Suppl 2:80-4.
51	Xie G, Wang X, Wang L, et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology 2012; 142:918-27.
	52.Pradere JP, Kluwe J, De Minicis S, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 2013; 58:1461-73.
53	Krizhanovsky V, Yon M, Dickins RA, et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134:657-67.
54	54.Chavez E, Castro-Sanchez L, Shibayama M, et al. Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4. J Appl Toxicol 2012; 32:51-9.
55	55.Kim KH, Chen CC, Monzon RI, et al. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol Cell Biol 2013; 33:2078-90.
56	Kong X, Feng D, Wang H, et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 2012; 56:1150-9.
57	Serrano M. Cancer: final act of senescence. Nature 2011; 479:481-2.
58	Senturk S, Mumcuoglu M, Gursoy-Yuzugullu O, et al. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology 2010; 52:966-74.
59	Qu K, Xu X, Liu C, et al. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin- induced senescence in hepatocellular carcinoma. Cancer Lett 2013; 331:105-14.
60	Lu WJ, Chua MS, So SK. Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth inhepatocellular carcinoma. Carcino- genesis 2014; 35:915-22.

[1]	Siwen Ouyang, Weiming Kang. Research Advances in the Role of Keratins in Gastrointestinal Cancer [J]. Chinese Medical Sciences Journal, 2022, 37(1): 73-78.
[2]	Xu Jia, Wang Xuan, Jin Zhengyu, You Yan, Wang Qin, Wang Shitian, Xue Huadan. Value of Texture Analysis on Gadoxetic Acid-enhanced MR for Detecting Liver Fibrosis in a Rat Model [J]. Chinese Medical Sciences Journal, 2019, 34(1): 24-32.
[3]	Wang Chun-yan, Liu Li-fang, Liu Xiao-li, Chen Wen-jun, He Guo-ping. Mechanisms of Lung Cancer Caused By Cooking Fumes Exposure: A Minor Review^△ [J]. Chinese Medical Sciences Journal, 2017, 32(3): 193-197.
[4]	Dong-qian Yi, Xue-feng Yang, Duan-fang Liao, Qing Wu, Nian Fu, Yang Hu, Ting Cao. Effect of Autophagy Over Liver Diseases [J]. Chinese Medical Sciences Journal, 2016, 31(1): 65-68.
[5]	Xuan Zhou, Xue-feng Yang. Progress of Targeting Transforming Growth Factor-β1 Small Interfering RNA in Liver Fibrosis [J]. Chinese Medical Sciences Journal, 2014, 29(4): 231-235.
[6]	Xiao-lun Huang,Le Luo,Lan-yun Luo,Hua Xue,Ling-ling Wei,Yu-tong Yao,Hai-bo Zou,Xiao-bing Huang,Yi-fan Zhu,Tian Zhang,Ping Xie,Mao-zhu Yang,Shao-ping Deng. Clinical Outcome of Autologous Hematopoietic Stem Cell Infusion via Hepatic Artery or Portal Vein in Patients with End-stage Liver Diseases [J]. Chinese Medical Sciences Journal, 2014, 29(1): 15-22.

Early edition

Current issue

Archive

Specialties & Topics

Author center

Reviewer center